Description

PharmaQo Dianabolan 50 is a pharmaceutical-grade injectable containing 50 mg/mL Methandrostenolone (Dianabol), studied in research settings for nitrogen retention, protein synthesis enhancement, and anabolic investigations related to tissue-wasting and recovery models.

Although traditionally used in oral form, the injectable version bypasses first-pass metabolism, allowing researchers to examine alternative pharmacokinetic and bioavailability profiles.

Product Details:
Active Ingredient:

• Methandrostenolone (Dianabol)

Concentration: 50 mg/mL

Form: Injectable solution (intramuscular)

Vial Size: 10 mL multidose vial

Pharmacokinetics:
Injectable methandrostenolone has an approximate half-life of 3–6 hours, often requiring daily administration in investigational settings.

Usage Recommendations:

• Indications (Research Context): Investigational use in anabolic support, muscle-wasting conditions, and recovery models (not approved for human use)

• Typical Dosage (Research Use): 25–50 mg per day, depending on protocol

• Monitoring: Liver enzymes, cardiovascular health, androgenic effects, lipid profile

• Cycle/Duration: Typically 4–6 weeks under research guidelines

Disclaimer:
This product is intended strictly for research and educational purposes. It is not for human consumption or therapeutic use. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with health risks. Always comply with local research laws and ethical standards.